@thelancetendo.bsky.socialAlthough highest shortly after treatment initiation, the risk [of #ketoacidosis with #SGLT2 inhibitors] persists over time and should be evaluated throughout treatment. Patients should be instructed to pause treatment during acute illness and stress thelancet.com/journals/lan...
#T2D #DKA
@springermedicine.com#MedNews - The risk for #ketoacidosis varies by patient characteristics among people with type 2 diabetes using #SGLT2 inhibitors and is apparent throughout treatment.
Full story 👉️ buff.ly/bA9G87d
@thelancetendo.bsky.socialAlthough highest shortly after treatment initiation [with #SGLT2 inhibitors], the risk [of #ketoacidosis] persists over time and should be evaluated throughout treatment. Patients should be instructed to pause treatment during acute illness and stress www.thelancet.com/journals/lan...
#DKA #T2D
@thelancetendo.bsky.social#Ketoacidosis risk with #SGLT2 inhibitors varies greatly by patient characteristics & is not confined to early in treatment. Risk should be assessed throughout treatment, & patients should be instructed to pause treatment during acute illness & stress www.thelancet.com/journals/lan...
#DKA #T2D
@thelancetendo.bsky.social#Ketoacidosis risk with #SGLT2 inhibitors varies greatly by patient characteristics and is not confined to early in treatment www.thelancet.com/journals/lan...
#DKA type 2 #diabetes #T2D
@thelancetendo.bsky.socialRisk of #ketoacidosis varies greatly by patient characteristics. As risk is not confined to shortly after treatment initiation, it should be considered throughout treatment, & patients should be instructed to pause therapy during acute illness & stress www.thelancet.com/journals/lan...
#DKA #SGLT2is